[ad_1]
By Adam Jourdan
SHANGHAI (Reuters) – Changsheng Biotechnology, the Chinese vaccine maker accused of falsifying data, plunged deeper into a crisis on Tuesday.
As a public outrage over the scandal snowballed this week, political leadership in Beijing, eager to maintain confidence in China's vaccine industry,
"Anything that touches on drug In China, "said Kent Kedl, Shanghai-based senior partner at Risk Control Consultancy.
he said, adding that the government needed to show a tough stance to ensure that it was not a problem that it was avoided.
"This is probably the highest level of the code of government"
China's drug regulator has accused Changsheng of fabricating production and inspection records related to rabies vaccine regularly given to infants. 252,600 DPT vaccine, a mandatory vaccine in China to inoculate children against diphtheria, whooping cough and tetanus.
While there were no known reports of people being harmed by the vaccine, Chinese regulators ordered Changsheng to halt production and recall the product. Changsheng, a billion-year-old Changsheng official publisher, said, "Changsheng's Shenzhen-listed shares plunged by their daily limit of 10 percent on Tuesday, reaching $ 1.8 billion or more. 19659002] Changsheng's chairwoman, three senior executives and two mid-level employees were taken for questioning by local police, the company said on Tuesday. The Central Commission for Discipline Inspection (CCDI), also said that it had begun to investigate into the firm.
Those probes are in addition to an investigation by the securities regulator, which is Changsheng violated information disclosure rules.
Sina Weibo microblogging over 600 million views.
"The Changsheng vaccine case has created a tsunami on the internet," the state-run Global Times newspaper said in an editorial late on Monday, adding it was unrealistic to try completely control it, though it could not be left unchecked.
"
The scandal has prompted the speculation that China would take their children China for vaccines as has" The Hong Kong Department of Health told Reuters local supply of vaccines remained stable and it would closely monitor the situation. Macau's health office said this was not enough.
($ 1 = 6.8204 Chinese Yuan)
(Reporting by Adam Jourdan; Additional Reporting by Farah Master and Anne Marie Roantree in Hong Kong and Ben Blanchard in Beijing; Editing by Edwina Gibbs)
(This story has not (f, b, e, v, n, t, s)
[ad_2]
Source link
